Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 19.83
+0.16 (0.81%)
At close: Aug 20, 2026
SHE:301263 Revenue
Guangdong Taienkang Pharmaceutical had revenue of 130.76M CNY in the quarter ending June 30, 2026, a decrease of -19.49%. This brings the company's revenue in the last twelve months to 648.09M, down -3.66% year-over-year. In the year 2025, Guangdong Taienkang Pharmaceutical had annual revenue of 674.90M, down -6.40%.
Revenue (ttm)
648.09M
Revenue Growth
-3.66%
P/S Ratio
15.55
Revenue / Employee
561.60K
Employees
1,154
Market Cap
10.08B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 674.90M | -46.13M | -6.40% |
| Jan 1, 2025 | 721.03M | -39.76M | -5.23% |
| Jan 1, 2024 | 760.79M | -22.69M | -2.90% |
| Jan 1, 2023 | 783.48M | 129.83M | 19.86% |
| Jan 1, 2022 | 653.65M | -55.33M | -7.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.